Search

Search Constraints

You searched for: Author/Creator Tigaud, Isabelle

Search Results

2. Higher percentage of CD34 + CD38− cells detected by multiparameter flow cytometry from leukapheresis products predicts unsustained complete remission in acute myeloid leukemia. Issue 3 (March 2015)

3. Measurable residual disease including AML leukemia stem cell flow evaluation of CPX-351 therapy by multi-parameter flow cytometry. (December 2021)

4. Neurofibromatosis‐1 gene deletions and mutations in de novo adult acute myeloid leukemia. Issue 4 (5th March 2013)

5. Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B‐cell lymphomas with MYC rearrangement. Issue 1 (25th September 2012)

6. Performances of Targeted RNA Sequencing for the Analysis of Fusion Transcripts, Gene Mutation, and Expression in Hematological Malignancies. Issue 2 (27th February 2021)

7. TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AML. (May 2017)

8. Treatment patterns and comparative effectiveness in elderly acute myeloid leukemia patients (age 70 years or older): the Lyon-university hospital experience. Issue 1 (2nd January 2017)